Lenz & Staehelin advised Beiersdorf and its luxury brand La Prairie in this transaction. Beiersdorf AG, the German listed parent behind the luxury brand La Prairie,...
Beiersdorf’s Acquisition of Real Estate Assets of Clinique La Prairie
Amundi’s Acquisition of Alpha Associates
Lenz & Staehelin advised Amundi in this transaction. Amundi signed an agreement to acquire Alpha Associates, a Swiss-based independent asset manager offering private markets multi-manager investment...
One Equity Partners’ Acquisition of Associated Spring and Hanggi From Barnes Group Inc.
Homburger advised One Equity Partners while Lenz & Staehelin advised Barnes Group Inc. on all Swiss related aspects of the transaction. Barnes Group Inc. (listed on...
Starrag Group’s Merger With Tornos
Lenz & Staehelin advised Starrag Group Holding AG and Tornos Holding AG on their merger. The two traditional Swiss precision machine tool manufacturers Starrag and Tornos,...
QSC LLC’s Acquisition of Seervision
Lenz & Staehelin advises Q-SYS in this transaction. Q-SYS, a division of US-based QSC LLC, has announced a definitive agreement to acquire Seervision, a Swiss-based industry...
Implenia’s Acquisition of Wincasa
Lenz & Staehelin advised Swiss Prime Site AG in this transaction. Swiss Prime Site AG signed an agreement to sell its Wincasa group company to Implenia...
OC Oerlikon’s Acquisition of Riri
Lenz & Staehelin advised the selling shareholders of RIRI Group in this transaction. Homburger advised OC Oerlikon. Oerlikon, a global innovation provider for surface engineering, polymer...
BorgWarner’s Acquisition of Drivetek AG
Lenz & Staehelin advised the selling shareholders of drivetek AG. BorgWarner announced the acquisition of drivetek AG, a Swiss company offering engineering and product development services...
Credit Suisse Asset Management’s Sale of Minority Stake in Energy Infrastructure Partners
Lenz & Staehelin advised Credit Suisse in this transaction. Credit Suisse Asset Management sold its minority stake in Energy Infrastructure Partners AG to the company’s co-founders...
ImmunOs Therapeutics’ CHF 71 Million Series B Financing Round
Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...
Taro Pharmaceutical Industries’ Acquisition of Alchemee
Cravath and Lenz & Staehelin represented Taro in connection with the transaction. Ropes & Gray advised Galderma. Taro Pharmaceutical Industries Ltd. (“Taro”), a multinational, science-based pharmaceutical...
SKAN Group AG’s Initial Public Offering on SIX Swiss Exchange
Lenz & Staehelin advised SKAN Group AG on the deal. SKAN Group AG announced the pricing of its IPO, consisting of 1,731,494 newly issued shares and...